Sunitinib Malate
Online Inquiry
| CAT# | Z10-101-140 |
| CAS | 341031-54-7 |
| Synonyms/Alias | SUNITINIB MALATE;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide(2S)-2-hydroxybutanedioatesalt;Sunitinib Malate(Sutent);Butanedioic acid, 2-hydroxy-, (2S)-, coMpd. with N-[2-(diethylaMino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihyd |
| M.F/Formula | C22H27FN4O2.C4H6O5 |
| M.W/Mr. | 532.566 |
| Application | Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.. A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic. Ant |
Write a review
Ask a question
My Review for Sunitinib Malate
Required fields are marked with *
×
Ask a Question for Sunitinib Malate
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
